Widespread use of statins for primary prevention could reduce risk of vascular events

Even patients with a 5-year risk for major vascular events <10% may benefit from primary prevention using statin therapy, according to the results of a large meta-analysis.

This study may hold particular significance for patients in India, where genetic susceptibility results in a higher rate of vascular events, and where the World Health Organization predicts that cardiovascular diseases (CVD) will be the largest cause of...